Houlihan Lokey Advises MedShift
Houlihan Lokey is pleased to announce the successful placement of a $108 million debt financing for MedShift, LLC. The transaction closed on March 31, 2023.
MedShift, a medical technology company founded in 2015 and headquartered in Charlotte, North Carolina, has emerged as a leader in the healthcare industry. The company caters to medical device manufacturers as well as individual medical practices and providers across various markets, including dermatology, gynecology, plastic surgery, and medspa.
MedShift operates through three technology divisions (device subscription, connected medical device, and enterprise SaaS), offering a comprehensive suite of innovative and cutting-edge solutions. In addition, MedShift provides a range of complementary products and services, such as device consumables and injectables that streamline the complex supply-and-demand landscape, providing a highly differentiated and value-creating experience for both medical device suppliers and medical providers.
Houlihan Lokey served as the financial advisor to the company and assisted in arranging, structuring, and negotiating the debt financing. Through thoughtful positioning and execution, Houlihan Lokey was able to drive a competitive financing process to achieve the company’s primary objectives, including (i) refinancing existing indebtedness in advance of near-term maturities, (ii) providing incremental liquidity to fund device purchases, and (iii) securing a highly flexible covenant package that provides management with meaningful operational flexibility. The transaction highlights cross-industry coordination within Houlihan Lokey to provide creative, efficient, and comprehensive solutions for its clients, particularly during times of market volatility.
Houlihan Lokey’s Capital Markets Group is one of the largest providers of private capital solutions in the world. Over the past two years, we raised approximately $25 billion in capital and advised on an additional $12 billion in capital over a total of 250+ transactions with more than 110 different financial sponsors.
Houlihan Lokey’s Healthcare Group is among the largest dedicated healthcare investment banking groups in the world. In 2022, the group closed 37 transactions and was ranked by Refinitiv as the No. 1 advisor for U.S. and global healthcare M&A transactions under $1 billion.*
Houlihan Lokey’s Financial Services Group is one of the leading financial services investment banking groups in the world. In 2022, the group closed 40 transactions and was ranked by Refinitiv as the No. 1 advisor for U.S. and global financial services M&A transactions under $1 billion.**
*Excludes accounting firms and brokers.
**Excludes bank transactions, accounting firms, and brokers.